Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years
- PMID: 28805477
- PMCID: PMC6190594
- DOI: 10.1080/1547691X.2017.1360968
Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years
Abstract
Perfluorinated alkylate substances (PFASs) are highly persistent and may cause immunotoxic effects. PFAS-associated attenuated antibody responses to childhood vaccines may be affected by PFAS exposures during infancy, where breastfeeding adds to PFAS exposures. Of 490 members of a Faroese birth cohort, 275 and 349 participated in clinical examinations and provided blood samples at ages 18 months and 5 years. PFAS concentrations were measured at birth and at the clinical examinations. Using information on duration of breastfeeding, serum-PFAS concentration profiles during infancy were estimated. As outcomes, serum concentrations of antibodies against tetanus and diphtheria vaccines were determined at age 5. Data from a previous cohort born eight years earlier were available for pooled analyses. Pre-natal exposure showed inverse associations with the antibody concentrations five years later, with decreases by up to about 20% for each two-fold higher exposure, while associations for serum concentrations at ages 18 months and 5 years were weaker. Modeling of serum-PFAS concentration showed levels for age 18 months that were similar to those measured. Concentrations estimated for ages 3 and 6 months showed the strongest inverse associations with antibody concentrations at age 5 years, particularly for tetanus. Joint analyses showed statistically significant decreases in tetanus antibody concentrations by 19-29% at age 5 for each doubling of the PFAS exposure in early infancy. These findings support the notion that the developing adaptive immune system is particularly vulnerable to immunotoxicity during infancy. This vulnerability appears to be the greatest during the first 6 months after birth, where PFAS exposures are affected by breast-feeding.
Keywords: Antibodies; developmental toxicity; immune functions; infancy; perfluorinated compounds; prospective study; vaccination.
Conflict of interest statement
Declaration of interest
The authors declare no conflicts of interest. The authors alone are responsible for the content of this manuscript.
Figures
Similar articles
-
Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.Environ Health Perspect. 2017 Jul 26;125(7):077018. doi: 10.1289/EHP275. Environ Health Perspect. 2017. PMID: 28749778 Free PMC article.
-
Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.JAMA. 2012 Jan 25;307(4):391-7. doi: 10.1001/jama.2011.2034. JAMA. 2012. PMID: 22274686 Free PMC article.
-
Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates.Environ Health. 2015 Jun 5;14:47. doi: 10.1186/s12940-015-0032-9. Environ Health. 2015. PMID: 26041029 Free PMC article.
-
[Persistant perfluorinated compounds cause immunotoxic effects].Ugeskr Laeger. 2014 Feb 24;176(9A):V09130572. Ugeskr Laeger. 2014. PMID: 25350410 Review. Danish.
-
Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies.Heliyon. 2021 Oct 12;7(10):e08160. doi: 10.1016/j.heliyon.2021.e08160. eCollection 2021 Oct. Heliyon. 2021. PMID: 34712855 Free PMC article. Review.
Cited by
-
Species-Specific Unbound Fraction Differences in Highly Bound PFAS: A Comparative Study across Human, Rat, and Mouse Plasma and Albumin.Toxics. 2024 Mar 29;12(4):253. doi: 10.3390/toxics12040253. Toxics. 2024. PMID: 38668476 Free PMC article.
-
Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells.Front Toxicol. 2024 Mar 14;6:1347965. doi: 10.3389/ftox.2024.1347965. eCollection 2024. Front Toxicol. 2024. PMID: 38549690 Free PMC article.
-
Improving care for veterans' environmental exposure concerns: applications of the consolidated framework for implementation research in program evaluation.BMC Health Serv Res. 2024 Feb 23;24(1):241. doi: 10.1186/s12913-024-10614-y. BMC Health Serv Res. 2024. PMID: 38395810 Free PMC article.
-
Prenatal Exposure to Poly- and Perfluoroalkyl Substances (2009-2014) and Vaccine Antibody Titers of Measles, Mumps, Rubella, and Varicella in Children Four to Eight Years Old from the Healthy Start Cohort.Environ Health Perspect. 2023 Dec;131(12):127018. doi: 10.1289/EHP12863. Epub 2023 Dec 26. Environ Health Perspect. 2023. PMID: 38147368 Free PMC article.
-
Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia.J Natl Cancer Inst. 2024 May 8;116(5):728-736. doi: 10.1093/jnci/djad261. J Natl Cancer Inst. 2024. PMID: 38092046 Free PMC article.
References
-
- Capua T, Katz J, Bocchini J. 2013. Update on adolescent immunizations: Selected review of U.S. recommendations and literature. Curr. Opin. Pediatrics 25:397–406. - PubMed
-
- CDC (Centers for Disease Control). 2015. Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention.
-
- Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, Galli C, Dell’Agli M, Germolec D. 2012. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol. Appl. Pharmacol 258:248–255. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials